Evotec CEO Wern­er Lan­thaler re­signs; Af­ter No­vo deal, ex-For­ma chief ush­ers in new era at Paci­ra

Wern­er Lan­thaler an­nounced his res­ig­na­tion as CEO of se­r­i­al Big Phar­ma part­ner Evotec on Wednes­day, and his for­mer COO Mario Poly­wka will fill in as in­ter­im chief un­til a per­ma­nent suc­ces­sor is named. Un­der Lan­thaler’s lead­er­ship, Evotec has formed al­liances with Take­da (RNA), Bris­tol My­ers Squibb (neu­ro dis­eases), Eli Lil­ly (meta­bol­ic dis­eases) and No­vo Nordisk (kid­ney dis­eases), among many oth­ers.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.